Tactile corpuscle

From WikiMD's WELLNESSPEDIA

(Redirected from Corpusculum tactus)

A Tactile corpuscle (also known as a Meissner's corpuscle or Ruffini ending) is a type of mechanoreceptor, a sensory receptor that responds to mechanical pressure or distortion. They are primarily located in the skin and are responsible for sensitivity to light touch. In particular, they have the highest sensitivity when sensing vibrations between 10 and 50 Hertz.

Structure[edit]

Tactile corpuscles are encapsulated unmyelinated nerve endings, which consist of flattened supportive cells arranged as horizontal lamellae surrounded by a connective tissue capsule. The corpuscle is between 30-140 μm in length and 40-60 μm in diameter. A single nerve fiber meanders between the lamellae and throughout the corpuscle.

Function[edit]

The primary function of the tactile corpuscle is to detect vibrations. When a pressure change is detected, the corpuscle reacts by creating an action potential that sends information to the central nervous system (CNS) about the pressure change. This allows the body to react to potentially harmful objects in the surrounding environment.

Clinical significance[edit]

Tactile corpuscles are responsible for the ability to feel light touch, and a decrease in number can lead to a decreased sensitivity to touch. This can occur in conditions such as diabetes, where a high blood sugar level can damage the nerves, including those of the tactile corpuscles.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.